Entries by Jack Aiello

2022 ASH Meeting | Multiple Myeloma Takeaways

Bookmark (0)

No account yet? Register

This is my 17th year attending ASH (American Society of Hematology), where typically over 30,000 attendees from all over the world (hematologists/oncologists, lab researchers, oncology nurses, scientists and 300 pharma […]

What’s a Patient Scientist?

Bookmark (0)

No account yet? Register

I recently attended a conference called “Patients As Partners” which focused on the benefits of Pharma companies using patients early during the development of clinical trials.  One company (I don’t […]

Myeloma Highlights – #ASH16

Bookmark (0)

No account yet? Register

MYELOMA HIGHLIGHTS FROM ASH CONFERENCE SAN DIEGO 12/2-6/2016 According to Jack Aiello (definitely not medically trained) PREFACE This is my 11th year attending ASH (American Society of Hematology) Conference, where 25,000 […]

Day 2: Can anything compare with eliminating 24-hr urine collections?

Bookmark (0)

No account yet? Register

Editor’s note: This blog was originally published by Jack Aiello on the International Myeloma Foundation’s website. Today’s events began with 9:30 a.m. education program on 1) managing Newly Diagnosed High-Risk […]

Myeloma Highlights from #ASH15

Bookmark (0)

No account yet? Register

According to Jack Aiello (definitely not medically trained) PREFACE This is my 10th year attending ASH (American Society of Hematology), where 25,000 attendees from all over the world (hematologists/oncologists, lab […]